|
000
| 01088nam##2200253za#4500 |
|---|
| 001 | 9.695024 |
|---|
| 003 | CaOODSP |
|---|
| 005 | 20210624234403 |
|---|
| 007 | cr ||||||||||| |
|---|
| 008 | 150407|2011||||xxc|||||o f|0| 0 eng|d |
|---|
| 020 | |a978-1-100-19411-0 |
|---|
| 040 | |aCaOODSP|beng |
|---|
| 043 | |an-cn--- |
|---|
| 086 | 1 |aH82-10/2011E-PDF |
|---|
| 110 | 1 |aCanada. |bPatented Medicine Prices Review Board. |
|---|
| 245 | 14|aThe impact of generic entry on the utilization of the ingredient |h[electronic resource] |
|---|
| 260 | |aOttawa - Ontario : |bPatented Medicine Prices Review Board |cSeptember 2011. |
|---|
| 300 | |a32p.|bcoloured figs., graphs, tables |
|---|
| 500 | |a"National Prescription Drug Utilization Information System, NPDUIS." |
|---|
| 590 | |a12-07|b2012-02-17 |
|---|
| 690 | 07|aDrugs|2gcpds |
|---|
| 690 | 07|aPharmaceutical industry|2gcpds |
|---|
| 775 | 08|tIncidence de l'arrivée sur le marché des médicaments génériques sur l'utilisation de l'ingrédient |w(CaOODSP)9.639185 |
|---|
| 856 | 40|ahttp://publications.gc.ca|qPDF|s783 KB|uhttps://publications.gc.ca/collections/collection_2012/cepmb-pmprb/H82-10-2011-eng.pdf |
|---|